Linked Data API

Show Search Form

Search Results

1649386
registered interest false more like this
date less than 2023-06-30more like thismore than 2023-06-30
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Influenza: Vaccination more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential impact of the decision not to renew the 50 to 64-year-old flu vaccination programme on (a) public health, (b) the economy and (c) NHS and social care capacity. more like this
tabling member constituency Bootle more like this
tabling member printed
Peter Dowd more like this
uin 191925 remove filter
answer
answer
is ministerial correction false more like this
date of answer less than 2023-07-10more like thismore than 2023-07-10
answer text <p>The Department is guided by the independent Joint Committee on Vaccination and Immunisation (JCVI) on the approach to the seasonal flu vaccination programme in England. Details about the flu vaccination programme for 2023/24, including which groups will be eligible for a free vaccine and the vaccines that will be reimbursable to National Health Service providers, were published on 25 May 2023. The groups eligible for a free flu vaccine for the 2023 to 2024 season include those aged 65 years old and over and those aged six months old to under 65 years old in clinical risk groups.</p><p>During the COVID-19 pandemic, eligibility for the influenza programme was temporarily extended to include all adults aged between 50 and 64 years old to protect the population from the potential threat of cocirculation of COVID-19 and influenza, and to alleviate pressure on the NHS. In the JCVI’s advice for the 2023/24 programme published in November 2022, it stated that whilst there would be a health benefit in vaccinating low-risk 50- to 64-year-olds, it is uncertain whether this would be cost effective, and that the overall priority should be to extend the childhood programme in secondary schools as this would be more cost effective and likely to have a greater impact on morbidity and mortality compared with vaccinating 50- to 64-year-olds.</p><p>Whilst there was no quantitative assessment made of additional indirect benefits to public health, the economy and NHS and social care capacity of not offering flu vaccinations to 50- to 64-year-olds this year, we did take into consideration qualitative evidence, including the benefits of seasonal flu vaccination on reducing winter pressures, when making our overall assessment. The Department will continue to be guided by JCVI advice on cost effectiveness.</p>
answering member constituency Lewes more like this
answering member printed Maria Caulfield more like this
grouped question UIN 192009 more like this
question first answered
less than 2023-07-10T16:24:06.35Zmore like thismore than 2023-07-10T16:24:06.35Z
answering member
4492
label Biography information for Maria Caulfield more like this
tabling member
4397
label Biography information for Peter Dowd more like this